Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-18
2010-11-30
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S082000
Reexamination Certificate
active
07842701
ABSTRACT:
The present invention provides a pyarzoloquinolone derivative having kinase inhibitory activity. The derivative is represented by the formula:wherein R1is an aryl group which may be substituted, or an aromatic heterocyclic group which may be substituted; R2is a hydrogen atom, an amino group which may be substituted, a hydroxy group which may be substituted, or a thiol group which may be substituted; R3, R4, R5and R6, which may be identical or different, are each (1) a hydrogen atom, (2) a nitro group, (3) a cyano group, (4) a halogen atom, (5) a hydrocarbon group which may be substituted, (6) an amino group which may be substituted, (7) a hydroxy group which may be substituted, or (8) a thiol group which may be substituted; and R3and R4, R4and R5, and R5and R6may respectively form a ring together with the adjacent carbon atom, or salt thereof.
REFERENCES:
patent: 6051577 (2000-04-01), Altmann
patent: 6268391 (2001-07-01), Dickerson et al.
patent: 0 476 544 (1992-03-01), None
patent: 5-132484 (1993-05-01), None
patent: 2000-506537 (2000-05-01), None
patent: 2002-514228 (2002-05-01), None
patent: WO 95/32205 (1995-11-01), None
patent: WO 01/42247 (2001-06-01), None
patent: WO 01/47892 (2001-07-01), None
patent: WO 03/004492 (2003-01-01), None
patent: WO 03/008409 (2003-01-01), None
Cecchi et al. “Synthesis and Binding Studies of 1-Arylpyrazolo [4,5-c]- and 2-Arylpyrazolo [4.3-c] Quinolin-4-Ones”.Farmaco. Edizione Scientifica. 1995. vol. 40 pp. 509-516.
International Search Report dated Apr. 5, 2005.
Fukumoto Shoji
Okaniwa Masanori
Tanaka Toshimasa
Yamamoto Takeshi
Hamre Schumann Mueller & Larson P.C.
Solola Taofiq A
Takeda Pharmaceutical Company Limited
LandOfFree
Pyrazoloquinolone derivative and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazoloquinolone derivative and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazoloquinolone derivative and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4252487